Noveris Health Sciences

(OTC) MYCOF

Current Price$1.00

Market Cap$1.24M

Since IPO (2015)-100%

5 Year-100%

1 Year+641%

1 Month-24%

Noveris Health Sciences Financials at a Glance

Market Cap

$1.24M

Revenue (TTM)

$0.00

Net Income (TTM)

$2.29M

EPS (TTM)

$1.33

P/E Ratio

0.75

Dividend

$0.00

Beta (Volatility)

0.00 (Low)

Dividend

$0.00

Beta (Volatility)

0.00 (Low)

Price

$1.00

Volume

Open

$1.00

Price

$1.00

Volume

Open

$1.00

Previous Close

$1.00

Daily Range

$1.00 - $1.00

52-Week Range

$0.01 - $1.40

Dividend

$0.00

Beta (Volatility)

0.00 (Low)

Price

$1.00

Volume

Open

$1.00

Previous Close

$1.00

Daily Range

$1.00 - $1.00

52-Week Range

$0.01 - $1.40

MYCOF News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Noveris Health Sciences

Industry

Pharmaceuticals

Sector

Health Care

Employees

CEO

David Joshua Bartch

Website

www.mydecine.com

Headquarters

Vancouver, BC V6E 3C9, CA

MYCOF Financials

Key Financial Metrics (TTM)

Gross Margin

Operating Margin

Net Income Margin

Return on Equity

Return on Capital

25%

Return on Assets

9452%

Earnings Yield

1.33%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$1.24M

Shares Outstanding

1.24M

Volume

Avg. Volume

782.318

Financials (TTM)

Gross Profit

$0.00

Operating Income

$2.49M

EBITDA

$2.48M

Operating Cash Flow

$37.32K

Capital Expenditure

$0.00

Free Cash Flow

$37.32K

Cash & ST Invst.

$325.00

Total Debt

$6.87M

Noveris Health Sciences Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q3 2025YOY CHG

Revenue

$0.00

N/A

Gross Profit

$0.00

N/A

Gross Margin

0.00%

N/A

Market Cap

$1.24M

N/A

Market Cap/Employee

$411.70K

N/A

Employees

N/A

Net Income

$73.79K

+103.7%

EBITDA

$107.70K

+106.7%

Quarterly Fundamentals

Name

Q3 2025YOY CHG

Net Cash

$6.90M

-6.6%

Accounts Receivable

$0.00

-100.0%

Inventory

$0.00

N/A

Long Term Debt

$0.00

N/A

Short Term Debt

$6.94M

+6.3%

Return on Assets

9451.85%

N/A

Return on Invested Capital

25.49%

N/A

Free Cash Flow

$9.60K

-42.3%

Operating Cash Flow

$9.60K

-42.3%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

VPHIFValeo Pharma Inc.

VPHIFValeo Pharma Inc.$0.00+0.00%

CHHEChina Health Industries Holdings, Inc.

CHHEChina Health Industries Holdings, Inc.$0.00+0.00%

BTCYBiotricity, Inc.

BTCYBiotricity, Inc.$0.26+11.83%

PTKFYPT Kalbe Farma Tbk.

PTKFYPT Kalbe Farma Tbk.$10.49+0.00%

LUFFFHerbal Dispatch Inc.

LUFFFHerbal Dispatch Inc.$0.05+5.08%

TELIFTelescope Innovations Corp.

TELIFTelescope Innovations Corp.$0.35+1.11%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

NOKNokia

NOKNokia$13.30+0.03%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$13.07+0.05%

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF$5.70+0.01%

SOFISoFi Technologies

SOFISoFi Technologies$16.43+0.02%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$65.30+0.03%

NIONio

NIONio$5.91-0.08%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$50.22-0.03%

Questions About MYCOF

What is the current price of Noveris Health Sciences?

Noveris Health Sciences is trading at $1.00 per share.

What is the 52-week range for Noveris Health Sciences?

Over the past 52 weeks, Noveris Health Sciences has traded between $0.01 and $1.40.

How much debt does Noveris Health Sciences have?

As of the most recent reporting period, Noveris Health Sciences reported total debt of $4.99M.

How much cash does Noveris Health Sciences have on hand?

Noveris Health Sciences reported $33,837.142 in cash and cash equivalents in its most recent financial results.

What is Noveris Health Sciences’s dividend yield?

Noveris Health Sciences does not currently have a dividend yield.

Noveris Health Sciences

Noveris Health Sciences Financials at a Glance

MYCOF News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Noveris Health Sciences

MYCOF Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Noveris Health Sciences Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About MYCOF

What is the current price of Noveris Health Sciences?

What is the 52-week range for Noveris Health Sciences?

How much debt does Noveris Health Sciences have?

How much cash does Noveris Health Sciences have on hand?

What is Noveris Health Sciences’s dividend yield?

Premium Investing Services